Opportunity Information: Apply for PA 17 226

Advancing the Science of Geriatric Palliative Care (R21) is a National Institutes of Health (NIH) discretionary grant opportunity designed to support early-stage, exploratory, or developmental research that can move geriatric palliative care forward. The central aim is to fund projects that create or refine new tools, methods, and models specifically tailored to the needs of older adults who may be living with serious illness, multiple chronic conditions, functional impairment, frailty, or complex care needs. Because it uses the NIH R21 mechanism, the opportunity is geared toward studies that test promising ideas, generate preliminary data, or demonstrate feasibility rather than large, definitive trials. The intent is to help researchers develop approaches that can later be scaled, validated, or tested in larger follow-on studies.

A major feature of this announcement is its broad view of where geriatric palliative care happens. It explicitly welcomes studies conducted across many real-world care environments, including hospitals and specific hospital locations such as specialty medical and surgical wards, intensive care units, and emergency departments. It also extends to post-acute care settings, outpatient clinics and physicians offices, patients homes and other residential settings, assisted living facilities, nursing homes, hospices, and other healthcare or community-based sites. This wide setting scope matters because older adults often move between care environments, and palliative care quality can depend heavily on how well care is coordinated across those transitions.

The FOA encourages flexible research approaches and is open to both new data collection and strong secondary analyses. Applicants can propose prospective studies, but they are also encouraged to analyze existing datasets and records, including health and medical records, claims data, and other data sources that can shed light on palliative care delivery and outcomes in geriatric populations. In practice, that means a project might involve mining electronic health record data to identify gaps in symptom management for older adults, evaluating patterns of healthcare utilization near the end of life, or studying how different care models affect outcomes such as comfort, caregiver burden, care transitions, and goal-concordant care. The announcement also signals that NIH is interested in efficient, resource-smart work by encouraging investigators to leverage existing cohorts, ongoing intervention studies, research networks, data and specimen repositories, and other established infrastructure. This emphasis makes it easier to propose a feasible R21 project while still addressing meaningful questions.

In terms of study design, the announcement allows a range of methods appropriate for developmental work. Observational studies are welcomed, as are quasi-experimental designs that can evaluate changes in care when randomization is not practical. Limited interventional studies are also considered appropriate when feasible under the R21 scope. Taken together, this means applicants are not confined to one methodology; they can match design to setting, data availability, and ethical or logistical constraints typical in serious illness research with older adults. The common thread is that the work should advance palliative care science by producing new approaches or evidence that can improve care for aging populations.

Eligibility is intentionally broad and includes many organization types that might contribute to geriatric palliative care innovation. Standard eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; tribal organizations other than federally recognized tribal governments; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; and other entities. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal government agencies, non-domestic (non-U.S.) entities (foreign organizations), regional organizations, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions. This broad eligibility reflects the reality that palliative care research and service innovation often emerge from diverse clinical systems and community partnerships, not only from traditional academic centers.

Key administrative details from the source information include the opportunity title and identifier (Funding Opportunity Number PA 17 226), the funding instrument (grant), and NIH as the sponsoring agency. The activity categories listed include education and health, and the CFDA numbers associated with the opportunity are 93.307, 93.361, and 93.866. The listed award ceiling is $200,000. The record shows an original closing date of 2017-12-15 and a creation date of 2017-03-20, which is useful context for timing and for determining whether an updated or reissued version of the FOA is currently active.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Advancing the Science of Geriatric Palliative Care (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307, 93.361, 93.866.
  • This funding opportunity was created on 2017-03-20.
  • Applicants must submit their applications by 2017-12-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 17 226

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Human-Animal Interaction (HAI) Research (R03)

Previous opportunity: Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 17 226

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 17 226) also looked into and applied for these:

Funding Opportunity
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 17 233

Funding Number: PAR 17 233
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,250,000
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) Apply for PAR 17 235

Funding Number: PAR 17 235
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Apply for PAR 17 240

Funding Number: PAR 17 240
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) Apply for PAR 17 234

Funding Number: PAR 17 234
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp) Apply for PA 17 241

Funding Number: PA 17 241
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) Apply for RFA DA 18 004

Funding Number: RFA DA 18 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) Apply for PA 17 243

Funding Number: PA 17 243
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Apply for PA 17 239

Funding Number: PA 17 239
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) Apply for PA 17 248

Funding Number: PA 17 248
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Apply for PAR 17 244

Funding Number: PAR 17 244
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Extracellular Vesicles and Substance Use Disorders (R21) Apply for PAR 17 242

Funding Number: PAR 17 242
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Apply for PAR 17 245

Funding Number: PAR 17 245
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Extracellular Vesicles and Substance Use Disorders (R01) Apply for PAR 17 250

Funding Number: PAR 17 250
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) Apply for RFA DA 18 005

Funding Number: RFA DA 18 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Nasal Delivery of CNS Therapeutics (R43/R44) Apply for RFA DA 18 006

Funding Number: RFA DA 18 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Nasal Delivery of CNS Therapeutics (R41/R42) Apply for RFA DA 18 007

Funding Number: RFA DA 18 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01) Apply for RFA MH 18 300

Funding Number: RFA MH 18 300
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21) Apply for RFA MH 18 301

Funding Number: RFA MH 18 301
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Genomic Community Resources (U24) Apply for PAR 17 273

Funding Number: PAR 17 273
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) Apply for PA 17 280

Funding Number: PA 17 280
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 17 226", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: